Ronny Isaac Drapkin MD PhD

Anatomic Pathology, Clinical Pathology

Professor (tenured), Director - Penn Ovarian Cancer Research Center, Director - Gynecologic Cancer Research, Basser Center for BRCA, University of Pennsylvania

Join to View Full Profile

421 Curie BoulevardBiomedical Res Bldg, 1215Philadelphia, PA 19104
Phone+1 215-746-3973

Summary

Dr. Ronny Drapkin is a physician-scientist in Philadelphia, PA affiliated with the University of Pennsylvania Perelman School of Medicine. He received his MD and PhD degrees from Rutgers Robert Wood Johnson Medical School followed by a residency in Pathology at the Brigham & Women's Hospital in Boston. He completed a postdoctoral fellowship at the Dana-Farber Cancer Institute before joining the faculty at Harvard Medical School and the DFCI. He was recruited to Penn in 2015 where he is the Franklin Payne Professor of Pathology in Gynecologic Oncology. He also speaks multiple languages, including Spanish. He has more than 250 publications and over 33,000 citations.

Education & Training

Dana-Farber Cancer InstitutePost-Doctoral Fellowship, 2001 - 2006
Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2001
Rutgers Robert Wood Johnson Medical SchoolClass of 1998
Rutgers Graduate School of Biomedical SciencesPhD, Biochemistry, 1992 - 1996
Brandeis UniversityBA, 1986 - 1990

Certifications & Licensure

MA State Medical License 2001 - 2016

Awards, Honors, & Recognition

Innovation Award Society of Gynecologic Oncology (SGO), 2024
Inducted Member American Association of Physicians (AAP), 2023
Rosalind Franklin Prize for Excellence in Ovarian Cancer Research Ovarian Cancer Research Fund Alliance, 2017
Inducted Member American Society for Clinical Investigation (ASCI), 2016
Research Award Mary Kay Foundation, 2010
Distinguished Alumnus Rutgers Graduate School of Biomedical Sciences, 2008
Best Research Abstract Prize Lynne Cohen Foundation for Ovarian Cancer Research, 2006
The Richter Award for Research Excellent in the School of Science Brandeis University, 1990
Join now to see all

Publications & Presentations

PubMed

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.
Lora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi, Collin M Coon, Saranya Rajendran
Cancer Research. 2025-04-03
Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube.
Ian Beddows, Svetlana Djirackor, Dalia K Omran, Euihye Jung, Natalie Nc Shih
Nature Communications. 2025-03-26
Aged and BRCA mutated stromal cells drive epithelial cell transformation.
Geyon L Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal
Cancer Discovery. 2025-03-14

Journal Articles

Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian Tumors
Leona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology

Press Mentions

Pitt Study Makes New Insights into the Origins of Ovarian CancerMarch 14th, 2025
Six Warning Signs of Ovarian CancerMay 8th, 2023
Five Bizarre Warning Signs of Ovarian Cancer RevealedMarch 7th, 2023
Join now to see all

Grant Support

SPORE in Ovarian CancerJOHNS HOPKINS UNIVERSITY2018–2029
PROTEOMIC GENETIC AND LONGITUDINAL PATHS TO OVARIAN CANCER BIOMARKER DISCOVERYNATIONAL CANCER INSTITUTE2014–2020
Cyclin E1 as a Therapeutic Target in Women with High-Grade Serous Ovarian Cancer and Primary Treatment FailurePMCC/Dept. of the Army – USAMRAA2015–2018
Cyclin E: Targeting Cell Cycle Dependencies in Ovarian CancerAdelson Medical Research Foundation (AMRF)2014–2017
ELAFIN AS A BIOMARKER IN SEROUS OVARIAN CANCERS AND BASAL-LIKE BREAST TUMORSNational Cancer Institute (NCI)2013–2015
PACIFIC OVARIAN CANCER RESEARCH CONSORTIUMNATIONAL CANCER INSTITUTE1999–2014
BACH1 Function In DNA Repair And Mammary OncogenesisNational Cancer Institute2005–2009